Positive Media Coverage Somewhat Unlikely to Impact Ventas (VTR) Share Price

Press coverage about Ventas (NYSE:VTR) has been trending positive this week, according to Accern Sentiment Analysis. The research group identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Ventas earned a coverage optimism score of 0.26 on Accern’s scale. Accern also assigned media stories about the real estate investment trust an impact score of 47.2666895713957 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Here are some of the news articles that may have effected Accern Sentiment Analysis’s analysis:

NYSE VTR opened at $56.96 on Monday. Ventas has a fifty-two week low of $46.55 and a fifty-two week high of $69.92. The company has a debt-to-equity ratio of 0.97, a quick ratio of 0.56 and a current ratio of 0.56. The stock has a market cap of $20.60 billion, a price-to-earnings ratio of 13.69, a P/E/G ratio of 3.64 and a beta of 0.14.

Ventas (NYSE:VTR) last posted its earnings results on Friday, July 27th. The real estate investment trust reported $1.08 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.02 by $0.06. Ventas had a return on equity of 5.02% and a net margin of 34.00%. The company had revenue of $942.30 million for the quarter, compared to analyst estimates of $919.95 million. During the same period last year, the company earned $0.42 earnings per share. The business’s revenue was up 5.2% compared to the same quarter last year. analysts anticipate that Ventas will post 4.04 earnings per share for the current fiscal year.

A number of research firms recently issued reports on VTR. Zacks Investment Research raised Ventas from a “sell” rating to a “hold” rating in a research report on Monday, April 16th. Bank of America lifted their price objective on Ventas from $55.00 to $60.00 and gave the company a “neutral” rating in a research report on Tuesday, July 10th. Hilliard Lyons raised Ventas from a “neutral” rating to a “buy” rating in a research report on Friday, April 27th. Cantor Fitzgerald reissued a “hold” rating and set a $56.00 price objective on shares of Ventas in a research report on Friday, July 27th. Finally, Evercore ISI cut Ventas from an “in-line” rating to an “underperform” rating in a research report on Monday, May 21st. Six investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company’s stock. Ventas currently has a consensus rating of “Hold” and an average price target of $57.07.

In other Ventas news, Chairman Debra A. Cafaro sold 30,942 shares of the firm’s stock in a transaction dated Tuesday, July 3rd. The stock was sold at an average price of $58.00, for a total transaction of $1,794,636.00. Following the transaction, the chairman now directly owns 775,109 shares in the company, valued at $44,956,322. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Chairman Debra A. Cafaro sold 15,505 shares of the firm’s stock in a transaction dated Friday, June 1st. The shares were sold at an average price of $55.00, for a total value of $852,775.00. Following the transaction, the chairman now owns 759,672 shares in the company, valued at $41,781,960. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 61,886 shares of company stock worth $3,496,556. Corporate insiders own 1.40% of the company’s stock.

Ventas Company Profile

Ventas, Inc, an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of more than 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, life science and innovation centers, inpatient rehabilitation and long-term acute care facilities, health systems and skilled nursing facilities.

Featured Article: Outstanding Shares, Buying and Selling Stocks

Insider Buying and Selling by Quarter for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply